2.75
전일 마감가:
$2.78
열려 있는:
$2.78
하루 거래량:
369.37K
Relative Volume:
0.25
시가총액:
$1.03B
수익:
$159.54M
순이익/손실:
$5.06M
주가수익비율:
-625.00
EPS:
-0.0044
순현금흐름:
$26.19M
1주 성능:
-3.85%
1개월 성능:
+0.36%
6개월 성능:
+2.61%
1년 성능:
+30.95%
Cronos Group Inc Stock (CRON) Company Profile
명칭
Cronos Group Inc
전화
(416) 504-0004
주소
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
2.75 | 1.03B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.56 | 52.88B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.76 | 42.98B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.95 | 38.37B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
75.56 | 31.68B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
547.06 | 23.22B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | Canaccord Genuity | Buy |
| 2022-11-02 | 개시 | Bernstein | Mkt Perform |
| 2022-07-28 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | 업그레이드 | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-27 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-11-18 | 재개 | BofA Securities | Underperform |
| 2021-04-28 | 재개 | BofA Securities | Underperform |
| 2021-02-22 | 다운그레이드 | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | 다운그레이드 | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | 업그레이드 | MKM Partners | Neutral → Buy |
| 2020-03-03 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-10-18 | 업그레이드 | Stifel | Hold → Buy |
| 2019-09-20 | 개시 | MKM Partners | Neutral |
| 2019-09-05 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | 개시 | Piper Jaffray | Overweight |
| 2019-08-09 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | 개시 | Consumer Edge Research | Equal Weight |
| 2019-06-06 | 개시 | Stifel | Hold |
| 2019-06-05 | 업그레이드 | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | 개시 | BofA/Merrill | Underperform |
| 2019-03-27 | 다운그레이드 | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | 개시 | Jefferies | Underperform |
| 2019-01-18 | 개시 | CIBC | Sector Outperform |
모두보기
Cronos Group Inc 주식(CRON)의 최신 뉴스
Promising Cannabis Stocks To Add to Your WatchlistJuly 11th - MarketBeat
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Why Are These Top 3 TSX Stocks in the Market Spotlight? - Kalkine Media
Cronos Group Inc. stock rises Thursday, still underperforms market - MarketWatch
Cronos Group Inc outlines cannabis strategy as industry evolves - ad-hoc-news.de
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Is Cronos Group (NASDAQ:CRON) Extending CanAdelaar Deal? - Kalkine Media
Cronos Group Holds Steady at $2.86 as Cannabis Sector Awaits CatalystsProtective Put - dars.gov.et
Cronos Group refines its cannabis strategy as investors weigh long-term growth prospects - ad-hoc-news.de
Cronos Group Inc.'s Equity Buyback announced on May 8, 2025, has expired. - marketscreener.com
Cronos appoints ATB Cormark as new broker for C... - Pluang
Cronos Group changes broker for share repurchase program - Investing.com
Cronos Group changes broker for share repurchase program By Investing.com - Investing.com India
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada - GlobeNewswire
Cronos Group (CRON) adds director Darren Chester Broughton as reporting insider on Form 3 - Stock Titan
TSX Penny Stocks To Watch In June 2026 - simplywall.st
CRONCronos Group Inc Volatility & Greeks - Finviz
Cronos Group Inc. stock rises Monday, still underperforms market - MarketWatch
Price to earnings forward of Cronos Group Inc – TSX:CRON - TradingView
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
CRON strengthens global footprint: Is the cannabis stock worth buying? - MSN
CRON Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (TSX:CRON) - TradingView
Cronos Group Inc Actuals & Estimates (FWB:7CI) - TradingView
7CI Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (NEO:CRON) - TradingView
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm
Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group Inc (CRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cronos Group shareholders approve board slate and auditor at annual meeting By Investing.com - Investing.com Australia
Form 8K CRONOS GROUP INC. For: 22 June By Investing.com - Investing.com India
Cronos Group Inc. (CRON) Announces 2026 Annual Meeting Results and Key SEC Filing Details - Minichart
Cronos Group shareholders approve board slate and auditor at annual meeting - Investing.com
Cronos Group shareholders re-elect directors and approve executive pay at 2026 annual meeting - Pluang
Cronos Group (NASDAQ: CRON) holders back pay and auditor at 2026 meeting - Stock Titan
Cronos Group StockAnalyst views and long-term cannabis strategy - AD HOC NEWS
Why Is Cronos Group Inc. (TSX:CRON) Rising After Buyback in S&P/TSX Composite Index? - Kalkine Media
Should Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors? - Yahoo Finance
Cronos Group Inc (CRON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CRON: All agenda items, including director elections and auditor appointment, were approved without dissent - TradingView
Cronos Extends Share Repurchase Program to Toronto Stock Exchange - Moomoo
Cronos Group Inc (CRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cronos Group Inc (CRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cronos Group Inc (CRON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cronos Group Inc (CRON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cronos Group Inc (CRON) Institutional Confidence - TradingKey
Cronos Group Inc (CRON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cronos Group Inc (CRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):